Royce & Associates’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$3.03M Buy
2024
Q3
$844K Buy
2024
Q2
Sell
2024
Q1
$570K Sell
2023
Q4
$522K Buy
2019
Q1
Sell
2018
Q4
$1.03M Buy